Clinical Trials Logo

Clinical Trial Summary

To compare the ability of 4 bleeding risk scoring systems (Glasgow -Blatchford score, MAP, H3B2 and ABC scores ) in prediction of: Need of intervention, Re bleeding, Thirty-day mortality, length of hospital stay


Clinical Trial Description

Acute upper gastrointestinal bleeding (UGIB) is a common medical emergency which has a variceal and non-variceal etiology. The non variceal etiology has higher incidence in many countries. In Egypt, non-variceal causes ranged from 26.1% to 61.6% among UGIB cases presented to the emergency departments of different University Hospitals. Guidelines recommend risk stratification early in the management of patients with acute UGIB to help triage patients into the appropriate level of care. Many scoring systems for UGIB were developed and validated from 1990s onwards. Their primary aim was to segregate the patients into low-risk and high-risk groups. High risk patients with UGIB includes those who reach some or all of the endpoints: requirement of blood transfusion, endo-therapeutic, surgical or radiological intervention to achieve hemostasis, re bleeding and mortality. Unfortunately, no single risk score has been shown to be accurate at measuring all relevant outcomes. The most widely used score is Glasgow Blatchford "GBS" which is a pre endoscopic score. It is useful in prediction of therapeutic intervention for bleeding. More recently, other scores have been developed as ABC score which showed good performance for predicting mortality. MAP score highly predicted therapeutic intervention and mortality. H3B2 score predicted the need of urgent hemostasis. Limited data are available on the validity of the new scoring systems in predicting the outcome of Egyptian non-cirrhotic patients with acute UGIB. Therefore, The investigators will conduct our study to shed some light on this topic. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06254352
Study type Observational
Source Assiut University
Contact Ahmed Gamal Abd elaal, resident doctor
Phone 01010995958
Email ahmed.sun1234@gmail.com
Status Not yet recruiting
Phase
Start date March 1, 2024
Completion date November 30, 2024

See also
  Status Clinical Trial Phase
Terminated NCT01448382 - Evaluation of PillCam With Blood-Sensing Feature: A Feasibility Study Phase 1
Recruiting NCT06167837 - Metoclopramide for Gastric Visualization in Active Upper GI Bleeding Phase 4
Recruiting NCT05746377 - Metoclopramide in Upper Gastrointestinal Bleed Phase 4
Recruiting NCT05582174 - PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers Phase 4
Recruiting NCT05415124 - Presence or Absence of Blood in the GI Lumen N/A
Recruiting NCT05474937 - Inhalation of Sevoflurane Versus Intravenous Midazolam,Ketamine,Propofol For Pediatrics Undergoing Upper GI Endoscopy N/A
Recruiting NCT05457062 - Analysis the Vocs in Upper GI Bleeding Patients
Recruiting NCT05876741 - Validation of Prognostic Accuracy of ABC ( Age, Blood Urea Nitrogen , Co-morbidities ) and Horibe Pre-endoscopy Scoring Systems in Patients With Upper Gastrointestinal Bleeding in Sohag University Hospital .
Recruiting NCT05763745 - Bedside Ultrasonic Assessment for Gastric Content in Patients With Upper GI Bleeding Undergoing Endoscopy: a Pilot Study N/A
Completed NCT03176407 - Detection of Upper Gastrointestinal (GI) Bleeding With a Novel Bleeding Sensor Capsule [DING] N/A